HAE vs MRNA · P/E 35, rev $1.33B vs rev $145.0M
Haemonetics Corporation (HAE) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the HAE and MRNA stock pages for the full models.
Not investment advice.